CN115120698A - 一种防脱发外用中药组合物及其制备方法 - Google Patents
一种防脱发外用中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN115120698A CN115120698A CN202211045464.5A CN202211045464A CN115120698A CN 115120698 A CN115120698 A CN 115120698A CN 202211045464 A CN202211045464 A CN 202211045464A CN 115120698 A CN115120698 A CN 115120698A
- Authority
- CN
- China
- Prior art keywords
- parts
- hair
- chinese medicine
- traditional chinese
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 98
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 230000003658 preventing hair loss Effects 0.000 title abstract description 11
- 210000004369 blood Anatomy 0.000 claims abstract description 56
- 239000008280 blood Substances 0.000 claims abstract description 56
- 241001289529 Fallopia multiflora Species 0.000 claims abstract description 21
- 210000003734 kidney Anatomy 0.000 claims abstract description 19
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 18
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 16
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 16
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 16
- 230000001737 promoting effect Effects 0.000 claims abstract description 16
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 15
- 210000004185 liver Anatomy 0.000 claims abstract description 15
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 13
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 13
- 230000017531 blood circulation Effects 0.000 claims abstract description 12
- 229940098465 tincture Drugs 0.000 claims abstract description 7
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract 3
- 201000004384 Alopecia Diseases 0.000 claims description 63
- 210000004209 hair Anatomy 0.000 claims description 50
- 229940079593 drug Drugs 0.000 claims description 38
- 231100000360 alopecia Toxicity 0.000 claims description 23
- 244000286838 Eclipta prostrata Species 0.000 claims description 16
- 241001522129 Pinellia Species 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 241000382455 Angelica sinensis Species 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 7
- 241001071917 Lithospermum Species 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 5
- 230000037396 body weight Effects 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 238000005728 strengthening Methods 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims description 3
- 235000002566 Capsicum Nutrition 0.000 claims 2
- 244000037364 Cinnamomum aromaticum Species 0.000 claims 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims 2
- 244000303040 Glycyrrhiza glabra Species 0.000 claims 2
- 241000112528 Ligusticum striatum Species 0.000 claims 2
- 239000006002 Pepper Substances 0.000 claims 2
- 235000016761 Piper aduncum Nutrition 0.000 claims 2
- 235000017804 Piper guineense Nutrition 0.000 claims 2
- 244000203593 Piper nigrum Species 0.000 claims 2
- 235000008184 Piper nigrum Nutrition 0.000 claims 2
- 241001643642 Viticis Species 0.000 claims 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims 2
- 235000011477 liquorice Nutrition 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract description 25
- 240000002045 Guettarda speciosa Species 0.000 abstract description 22
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract description 17
- 241000202726 Bupleurum Species 0.000 abstract description 15
- 235000006886 Zingiber officinale Nutrition 0.000 abstract description 14
- 235000008397 ginger Nutrition 0.000 abstract description 14
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 13
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 13
- 229940010454 licorice Drugs 0.000 abstract description 13
- 241000748223 Alisma Species 0.000 abstract description 12
- 244000089698 Zanthoxylum simulans Species 0.000 abstract description 12
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 abstract description 10
- 235000005865 Symphytum officinale Nutrition 0.000 abstract description 9
- 244000273928 Zingiber officinale Species 0.000 abstract description 8
- 210000000952 spleen Anatomy 0.000 abstract description 6
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 5
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract description 4
- 235000017803 cinnamon Nutrition 0.000 abstract description 4
- 244000061520 Angelica archangelica Species 0.000 abstract description 3
- 235000015655 Crocus sativus Nutrition 0.000 abstract description 2
- 244000124209 Crocus sativus Species 0.000 abstract description 2
- 240000002299 Symphytum officinale Species 0.000 abstract description 2
- 235000013974 saffron Nutrition 0.000 abstract description 2
- 239000004248 saffron Substances 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 238000012552 review Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 41
- 230000003676 hair loss Effects 0.000 description 39
- 208000024963 hair loss Diseases 0.000 description 37
- 210000003491 skin Anatomy 0.000 description 37
- 230000000694 effects Effects 0.000 description 35
- 210000003780 hair follicle Anatomy 0.000 description 30
- 201000010099 disease Diseases 0.000 description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 25
- 241000699670 Mus sp. Species 0.000 description 23
- 230000003779 hair growth Effects 0.000 description 20
- 239000000796 flavoring agent Substances 0.000 description 19
- 235000019634 flavors Nutrition 0.000 description 19
- 208000003251 Pruritus Diseases 0.000 description 17
- 210000004761 scalp Anatomy 0.000 description 17
- 208000011580 syndromic disease Diseases 0.000 description 17
- 241000110847 Kochia Species 0.000 description 16
- 241000736199 Paeonia Species 0.000 description 15
- 230000007803 itching Effects 0.000 description 15
- 238000000034 method Methods 0.000 description 15
- 241000246044 Sophora flavescens Species 0.000 description 14
- 240000003243 Thuja occidentalis Species 0.000 description 14
- 235000008109 Thuja occidentalis Nutrition 0.000 description 14
- 241000132012 Atractylodes Species 0.000 description 13
- 241000202807 Glycyrrhiza Species 0.000 description 13
- 239000008713 qiang-huo Substances 0.000 description 13
- 235000001188 Peltandra virginica Nutrition 0.000 description 12
- 235000008599 Poria cocos Nutrition 0.000 description 12
- 235000008708 Morus alba Nutrition 0.000 description 11
- 240000000249 Morus alba Species 0.000 description 11
- 235000009347 chasteberry Nutrition 0.000 description 11
- 210000003128 head Anatomy 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 241000234295 Musa Species 0.000 description 10
- 241001446509 Psoralea Species 0.000 description 10
- 241000532412 Vitex Species 0.000 description 10
- 230000000144 pharmacologic effect Effects 0.000 description 10
- 244000197580 Poria cocos Species 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 230000004069 differentiation Effects 0.000 description 8
- 230000008506 pathogenesis Effects 0.000 description 8
- 230000000007 visual effect Effects 0.000 description 8
- 241001442052 Symphytum Species 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 240000003173 Drymaria cordata Species 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 6
- 241000234314 Zingiber Species 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000002500 effect on skin Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 230000004089 microcirculation Effects 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 244000304217 Brassica oleracea var. gongylodes Species 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000036770 blood supply Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000005713 exacerbation Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000000384 rearing effect Effects 0.000 description 4
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 3
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 3
- 240000005001 Paeonia suffruticosa Species 0.000 description 3
- 244000248825 Peltandra virginica Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 230000003695 hair diameter Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229960003632 minoxidil Drugs 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- 241000213006 Angelica dahurica Species 0.000 description 2
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 2
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 2
- 244000236658 Paeonia lactiflora Species 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000004631 alopecia areata Diseases 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000003412 degenerative effect Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000035617 depilation Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 229940000406 drug candidate Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003777 experimental drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 210000000442 hair follicle cell Anatomy 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 230000036732 histological change Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 229960001712 testosterone propionate Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000019590 thick flavour Nutrition 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 102100033875 3-oxo-5-alpha-steroid 4-dehydrogenase 2 Human genes 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102000015735 Beta-catenin Human genes 0.000 description 1
- 108060000903 Beta-catenin Proteins 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 108010024212 E-Selectin Proteins 0.000 description 1
- 102100023471 E-selectin Human genes 0.000 description 1
- 208000030814 Eating disease Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000019454 Feeding and Eating disease Diseases 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 101000640851 Homo sapiens 3-oxo-5-alpha-steroid 4-dehydrogenase 2 Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 description 1
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 241001466061 Nematomorpha Species 0.000 description 1
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 1
- 101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 1
- 240000004370 Pastinaca sativa Species 0.000 description 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 241000745988 Phyllostachys Species 0.000 description 1
- 244000302661 Phyllostachys pubescens Species 0.000 description 1
- 235000003570 Phyllostachys pubescens Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- 241000529915 Xylophilus Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 241000949456 Zanthoxylum Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000020980 bad eating habits Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000007418 data mining Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 235000014632 disordered eating Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000003803 hair density Effects 0.000 description 1
- 230000009583 hair follicle growth Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- -1 lipid peroxides Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000021062 nutrient metabolism Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000013166 platelet test Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药领域,更具体地说,是涉及一种防脱发外用中药组合物及其制备方法。本发明提供一种预防脱发的外用中药组合物,其组成为:苦参、白鲜皮、地肤子、侧柏叶、桑叶、土茯苓、百部、半夏、石菖蒲、苍术、川芎、当归、鸡血藤、红花、牡丹皮、赤芍、紫草、防风、羌活、蔓荆子、白芷、车前草、泽泻、墨旱莲、何首乌、柴胡、桂枝、干姜、花椒、补骨脂、仙灵脾、甘草、薄荷。本发明制备的酊剂具有祛热燥湿、滋补肝肾、活血祛瘀和固发防脱的功效且制备方法简单,效果显著,且本发明属纯中药外用制剂,无肝肾功能损害,安全性评价良好。
Description
技术领域
本发明涉及中药领域,更具体地说,是涉及一种防脱发外用中药组合物及其制备方法。
背景技术
脱发为现代临床的常见病,多见于青壮年男性,以前额、颞部两侧发际线逐渐上移,头顶部头发稀疏,甚或脱落为主要表现,有碍观瞻,严重影响患者身心健康及日常工作学习,故近年来,多学科多领域的专家对这一疾病均展开了系列深入的探讨与研究。现代医学尚未明确阐述其病因病机,认为与免疫、遗传、激素使用、局部炎症、神经内环境等因素关系密切。此外,精神心理焦虑紧张、膳食失调及病菌感染等亦可诱发或加重病情。针对本病,临床治疗较为棘手,常予以非那雄胺片、米诺地尔片等药物口服治疗,严重者可予以自体毛囊移植术治疗。虽可在一定程度上奏效,但尚不能实现长期有效的治疗目标。
脱发属中医学中“蛀发癣”、“发蛀脱发”等疾病范畴,追古溯源,关乎本病的记载首见于后清《外科证治全书》一书,其病因病机可概述为或因纵食肥甘厚味,或因情志不遂化火,或因劳神费力耗血,或因风湿热上蒸于巅。使得气血循行不畅,清窍失于濡养,毛发不固,毛根空虚,发为脱落。综上,脱发的发生于肝脾肾三脏关系密切,以肝、肾、脾虚为本,以风、湿、热搏结为标,病性具有虚实夹杂的特点。
由于脱发病情繁杂,病程延绵,使得现阶段的临床防治工作面临巨大挑战,故采取积极有效的治疗方案及举措,改善临床症状,减缓疾病进程,提高生活质量显得尤为重要。
发明内容
本发明在药物剂型上,改良和优化现有方剂,研制出有高效且副作用小的中药固发外用制剂的形式对患者施以治疗。
在组方原则上,将中医药理论与现代药理学研究结合,筛选出具有抗菌消炎、改善毛囊活性、促进毛发生长发育的中药成分。
在遣方用药上,利用药物的四气五味、性味归经、功效主治,选择具有祛热燥湿、滋补肝肾、凉血养阴、活血祛瘀、养血生新功效的具体药味。
全方所用药物功效全面、疗效确切,谨守病机,贯穿脱发发生、发展及预后全过程,覆盖脱发临床涉及的几乎所有证型,是“扶正祛邪”、“标兼顾”“整体论治”等中医防治理念的具体实践。
为了实现上述目的,本发明提供如下技术方案。
本发明提供一种治疗脱发的外用中药,按重量份数计,其组成及重量配比为:苦参10~20份、白鲜皮10~30份、地肤子10~20份、侧柏叶15~30份、桑叶15~30份、土茯苓15~20份、百部10~15份、半夏10~15份、石菖蒲15~20份、苍术10~30份、川芎10~25份、当归10~25份、鸡血藤10~25份、红花10~25份、牡丹皮10~20份、赤芍10~20份、紫草10~20份、防风10~20份、羌活10~30份、蔓荆子10~30份、白芷10~25份、车前草10~25份、泽泻10~30份、墨旱莲10~30份、何首乌10~30份、柴胡10~25份、桂枝10~20份、干姜10~25份、花椒5~15份、补骨脂10~30份、仙灵脾10~30份、甘草10~20份、薄荷10~25份。
所述的治疗脱发的外用中药,按重量份数计,其组成及重量配比优选为:苦参15g、白鲜皮15g、地肤子15g、侧柏叶15g、桑叶15g、土茯苓20g、百部15g、半夏10g、石菖蒲15g、苍术15g、川芎15g、当归15g、鸡血藤15g、红花10g、牡丹皮15g、赤芍15g、紫草10g、防风15g、羌活15g、蔓荆子15g、白芷15g、车前草15g、泽泻15g、墨旱莲15g、何首乌15g、柴胡15g、桂枝10g、干姜15g、花椒10g、补骨脂15g、仙灵脾15g、甘草15g、薄荷12g。
本发明提供一种上述的治疗脱发的外用中药制备方法,将上述中药饮片以300ml75%的酒精泡制两周后,药渣丢弃,倒取上清药液,制得。
所述的中药组合物在制备治疗祛热燥湿、滋补肝肾、活血祛瘀和固发防脱的功效药物中的用途。
进一步的,所述的中药组合物剂型为为酊剂。
进一步的,使用本酊剂擦拭脱发局部,所述的临床用药量根据人体体重计算,每次用量为0.035g所述药物对应于1千克人体体重,2次/日。
本发明的各原料的药理功效如下。
中医学认为,脱发与肝肾不足、湿热熏蒸、痰瘀互结、血热风燥关系密切,病性多属本虚标实之证。首先,发为血之余,精血同源,肝肾亏损,水亏木郁,毛根空虚,毛发失其养滋之源,故枯槁易脱,治疗当滋补肝肾,养血填精,培补根本。其次,标为致病邪气,湿热、血热熏灼蒸腾,热久化燥,极而生风,头处阳位,发处人体之巅,易受风邪侵袭,犹如风吹叶落,发丝飘零,故治疗当兼顾祛热燥湿、滋补肝肾、凉血养阴、活血祛瘀、养血生新等方面,邪去正安,固本防脱。此外,由于脱发病位责之于体表皮肤,易进行性加重,因此采用中药外用制剂擦拭患处,可实现药效直达病灶的治疗目标,且外用制剂能完美契合局部长期治疗需求。
本发明中运用苦参、白鲜皮、地肤子、侧柏叶、桑叶、红花、牡丹皮、赤芍、墨旱莲、何首乌等药味组成,全方配伍严谨,以苦参、白鲜皮、土茯苓、地肤子、百部为君;以当归、鸡血藤、红花、川芎、牡丹皮、赤芍、侧柏叶为臣;以紫草、白芷、蔓荆子、薄荷、防风、羌活、半夏、石菖蒲、苍术为佐;以柴胡、桂枝、干姜、花椒、墨旱莲、补骨脂、仙灵脾、何首乌为使。苦参、白鲜皮、土茯苓、地肤子、百部奏以清热燥湿、杀虫止痒之效。现代药理学研究表明,苦参提取物具有抑制Ⅱ型5α-还原酶活性的作用,平衡油脂分泌,疏通并收敛毛孔,促进受损血管的生长和修复,恢复皮下毛细血管细胞活力,局部用药可加速血液循环,改善毛囊活性,实现促进毛发生长的治疗目的。白鲜皮清热燥湿、祛风解毒,《本草正义》:土茯苓,利湿去热,能入络,搜剔湿热之蕴”,故二者合用,可奏“眉发脆脱”之效。实验研究结果表明,白鲜皮所含有的药物成分虽不能阻止环磷酰胺诱导大鼠脱发,但对其诱导损伤毛囊具有对抗作用,对大鼠毛发生长也具有促进作用,且这一作用与其抗炎、免疫抑制有关。地肤子、百部祛风止痒、灭虱杀虫,《诸病源候论·毛发病诸候》言:“凡人皆有九虫在腹内……言白秃者,皆由此虫所作,谓在头生疮有虫,白痂甚痒,其上发并秃落不生,故谓之白秃”,指出脱发与虫邪侵袭有关,因此中医防止脱发时还需遣以杀虫之药。《本草原始》言:“去皮肤中积热,除皮肤外湿痒”,《抱朴子》中言:“治咳及杀虫”。药理学研究指出,地肤子水浸剂(1:3)对许兰氏黄癣菌、奥社盎氏小芽胞癣菌等皮肤真菌具有一定的抑制作用。百部水浸液及乙醇浸液可将其所含有的百部定碱、异百部定碱、原百部碱充分析出,局部涂擦毛囊可起到抗菌消炎、杀虫止痒的作用。
继以当归、鸡血藤、红花、川芎、牡丹皮、赤芍、侧柏叶,奏行气活血、凉血祛瘀生发之功效。《血证论·瘀血》言:“瘀血在上焦,或发落不生。”《医林改错》言:“皮里肉外血瘀,阻塞血络,新血不能养发,故发落。”《儒门事亲》言:“年少发白早落,此血热太过也”可见血虚、血瘀、血热均与毛发生长密切相关,故通调血运在防治脱发过程中尤为重要。本方以当归养血活血,散瘀;鸡血藤补血活血,通络;红花活血通经,散瘀;牡丹皮、赤芍合用,清解营热、凉血祛瘀,辅以血中之气药的川芎,行气开郁,治上部之疾尤良,于补血方中配用,助其补血养血凉血、祛瘀通经之力,同时亦体现本次组方“补中有泻、泻中寓补”之意。侧柏叶凉血润燥,《本草纲目》论述松叶(即侧柏叶)为“风湿疮,生毛发,安五脏,守中,不饥延年,能生须发”,配之“补营圣药”当归,既活血生血,又可获得毛发新生的效果。研究表明,当归加快局部代谢,扩张微血管,提升细胞氧合能力,为毛囊提供营养成的同时,其含有类雌激素样药物成分,可抗雄激素,调控免疫功能,改善毛囊局部内环境活性,从而减缓脱发。侧柏叶所含有的挥发油成分(雪松醇)可改善头皮部位血液微循环,加强细胞养分,刺激毛囊生长,促进毛发的生长。丹皮酚通过增强皮肤毛细血管通透性,使得其有效成分充分进入血液,发挥抗炎抑菌的药效。赤芍抗炎的化学成分为赤芍总苷,其抗凝血、抗血栓作用机制系由通过抑制促炎性介质如肿瘤坏死因子-α(TNF-α)、IL-1β、iNOS、环氧合酶-2(COX-2)、5-脂氧酶(5-LOX)的上调,改善G蛋白偶联受体信号转导的过度脱敏,降低炎症因子水平。体外人血小板试验发现,牡丹皮水提物及芍药酚均能抑制血小板花生四烯酸产生血栓素A2,抑制血小板聚集,调控血流动力学循环,维持局部血运正产供给,进而保护受损毛囊活性。川芎乙醇提取物具有调节血小板聚集速率的作用,局部涂擦治疗时可刺激毛细血管敏感性,调节皮肤毛囊血液循环,起到活血祛瘀、促进毛发生长的作用。
脱发病位在头部,取象比类,乃为高山之巅,故惟风可到,易受风邪;湿热、血热和血虚皆可生风,风为阳邪,走散不定,脱发之性状,犹如风吹叶落,因此加紫草、白芷、蔓荆子、薄荷、防风、羌活等祛风药。其意在:借风药之力,携药上行,使药效直达病灶;又因脱发常见血热或阴虚生风之证,凭风药升散之性,奏祛风止痒,调治瘙痒之效。此外,风药为使,可分经论治,根据病位分区经脉所过不同,所遣得引经药各异,如病在前额以白芷入阳明;病在头顶以蔓荆子入厥阴;病在后头部以羌活入太阳;病在头侧以防风、柴胡入少阳。现代研究指出,薄荷具有抗炎镇痛、抗真菌、抗病毒等作用,其有效成分薄荷醇和薄荷脑通过改变皮肤角质层结构来促进药物吸收,是外用药物渗透剂的最佳介质载体。
脱发者多有纵食肥甘厚味,生冷不忌的不良饮食习惯,致使脾为损伤,运化失职,痰浊内生,循经上行,湿滞发根,浸蚀毛囊,毛发失养,发为遗落。痰浊阻滞日久,郁而化热,乃或生瘀,阻碍气血运行,致使旧发不固,新发不生。半夏、石菖蒲、苍术燥湿和胃,调平寒热,开解清窍,以期脾胃复常,湿浊内化,郁热自清,毛发得养。因水湿浸淫头部,治法可上病下取,疏利水湿,发根不为水浸,毛发则坚固不脱,故遣以气味俱薄之车前草、泽泻清热渗湿,利水下行,导浊下降,亦合乎“先其所因,伏其所主”的中医诊治理念。
毛囊是皮肤的组成部分之一,其生长代谢有赖于气血津液的供给,共同维持正常的生理功能。少阳经在经脉循行中起起到了转输内外的枢纽作用。少阳转枢功能正常,气血营卫的输布正常,则肌肤毛囊肌润泽,反之,少阳枢机不利,毛囊代谢异常,毛发不固,继而遗落。故本方取柴胡桂枝干姜汤之意,遣柴胡、桂枝、干姜三味,联合花椒,清解郁热、疏利肝胆,调和阴阳,杀虫止痒。顾世澄在《疡医大全》中言:“花椒四两,用白酒酿七日,早晚润秃处,其处自生。”同时也是中医循证治疗“外病内治”的理论发挥。柴胡疏利气机,和解少阳;桂枝、甘草辛甘化阳,调畅津液;干姜与甘草相伍,将太阴之邪转入少阳,上三味共奏寒热并调,清上温下之功。
“发乃血之余,枯者,血不足也。忽然脱落,头皮多痒,须眉并落者,乃血热生风,风木摇动之象也”,故治脱发之本,重在固肾,肾精充足,荣养有源,方能毛发根基坚牢不脱,故治疗法当以滋补肝肾,充盈精血为其大法,故以墨旱莲益肾阴,补骨脂补肾阳,仙灵脾填精血,何首乌固须发。墨旱莲所含有的黄酮类化合物能够扩张血管弹性,抑制血小板凝聚,调控凝血酶活性,对·OH、O2-自由基具有较强的清除力,减少脂质过氧化物,从调节免疫、内分泌等方面延缓毛发脱落。补骨脂素可改善血液循环,抗菌祛脂,增加雌二醇及卵泡生成素寒露,进而实现抗雄防脱的作用。何首乌利于毛囊产生,制首乌补肝肾、益精血、助生发,药理研究证实,何首乌可改善毛囊血运、抑制皮脂腺分泌,抑制毛囊细胞凋亡,防止脱发。同时其还可通过调控成纤维生长因子、β-连环蛋白等含量促进毛发生长,起到生发的目的。与此同时,以上四味,其色均黑,诚如《素问·宝命全形论》所言“天覆地载,万物悉备,莫贵于人,人以天地之气生,四时之法成”,人与天地相参,与日月相应,基于此本于药,本方遣用此药亦体现“取象比类、同气相求、以类补类”之意,黑色入肾,故可固肾益精,防脱生发。
一种防脱发外用中药组合物药味诸多,功效全面,结合药味四气五味,严密契合脱发的病机特点,覆盖本病发生、发展各阶段的疾病特点,中医药理论与现代药理实验研究的结合,利于丰富临床治疗脱发的技术手段,为患者带来福音。同时,药味的使用体现中医经络-脏腑相关理论。结合病位涉及脏腑,病灶发生部位,本方药味的配伍应用,符合中西医药理学理论,故本方的药味总体数量不可或缺,无需过多运用同类功效的药物,避免药味数量过于繁多,功效过于冗杂,副作用过于猛烈。其次,在各药味剂量的确定问题上,根据该类患者体质、形态、身高、体重等常规一般情况确定了药物剂量具体适用范围,因人制宜,个性化灵活运用,尽可能实现药效最佳化,实现临床治疗的目的,无需过量使用药物,避免药物所产生的副作用或药物其他作用影响全方整体疗效。
与现有技术相比,具有的有益技术效果。
本发明所遣方药,与现有相关中医药防治脱发的外用制剂相比,治疗原则严密契合病因病机病性特点,辨证思维充分结合脏腑辨证、六经辨证、经络辨证,是中医学防治举措“整体观念”“标本兼顾”“邪正统筹”的理念体现,是中医循证治疗的有益探索和发现。全方药味谨守病机,全面覆盖脱发发生、发展过程中衍生的系列证候类型,是中医学“整体观念”、“辨证论治”理论体系的切实运用。
一种防脱发外用中药组合物经乙醇浸泡后制成酊剂,直接涂擦在头部,有效直接作用于头部,减缓疾病进程,可抗菌消炎,改善毛囊微循环,减少头皮油脂分泌,改善头皮降低瘙痒,促进毛发生长。且酊剂较膏剂、油剂等制作方便,不易污染衣物,易于被大众所受。一种防脱发外用中药组合物的研发,全程不离中医学“理(病理医理)、法(治疗方法)、方(经方+时方)、药(辨证用药)、术(外用制剂)”的诊疗精髓。
本发明制备的酊剂,具有祛热燥湿、滋补肝肾、活血祛瘀和固发防脱的功效且制备方法简单,效果显著,且本发明属纯中药外用制剂,无肝肾功能损害,安全性评价良好。
具体实施方式
实施例1。
1、组方具体用量、制备方法。
组方具体用量:苦参15g、白鲜皮15g、地肤子15g、侧柏叶15g、桑叶15g、土茯苓20g、百部15g、半夏10g、石菖蒲15g、苍术15g、川芎15g、当归15g、鸡血藤15g、红花10g、牡丹皮15g、赤芍15g、紫草10g、防风15g、羌活15g、蔓荆子15g、白芷15g、车前草15g、泽泻15g、墨旱莲15g、何首乌15g、柴胡15g、桂枝10g、干姜15g、花椒10g、补骨脂15g、仙灵脾15g、甘草15g、薄荷12g。
制备方法:将上述中药饮片以300ml75%的酒精泡制两周后,药渣丢弃,倒取上清药液,擦拭局部,2次/日。
实施例2。
本实施例中,辨证为肾精亏虚、痰瘀互结证,治疗脱发外用中药,其组成及重量配比为:苦参10g、白鲜皮10g、地肤子10g、侧柏叶15g、桑叶15g、土茯苓15g、百部10g、半夏10g、石菖蒲15g、苍术10g、川芎10g、当归10g、鸡血藤10g、红花10g、牡丹皮10g、赤芍10g、紫草10g、防风10g、羌活10g、蔓荆子10g、白芷10g、车前草10g、泽泻10g、墨旱莲10g、何首乌10g、柴胡10g、桂枝10g、干姜10g、花椒5g、补骨脂10g、仙灵脾10g、甘草10g、薄荷10g。将上述中药饮片以300ml 75%的酒精泡制两周后,药渣丢弃,倒取上清药液,擦拭局部,2次/日即可。
实施例3。
本实施例中,辨证为血热风燥证,治疗脱发外用中药,其组成及重量配比为:苦参20g、白鲜皮30g、地肤子20g、侧柏叶30g、桑叶30g、土茯苓20g、百部15g、半夏15g、石菖蒲20g、苍术30g、川芎25g、当归25g、鸡血藤25g、红花25g、牡丹皮20g、赤芍20g、紫草20g、防风20g、羌活30g、蔓荆子30g、白芷25g、车前草25g、泽泻30g、墨旱莲30g、何首乌30g、柴胡25g、桂枝20g、干姜25g、花椒15g、补骨脂30g、仙灵脾30g、甘草20g、薄荷25g,将上述中药饮片以300ml75%的酒精泡制两周后,药渣丢弃,倒取上清药液,擦拭局部,2次/日即可。
实施例4。
中药药理学研究。
中医学处方用药是在辨证论治的基础上,根据药量与疗效的相关性,把控用药策略以随证施量,正所谓“中医不传之秘在药量”。方药剂量是辨证遣方后的重要步骤,是疗效实现的重要影响因素。剂量是预计疗效的准绳,疗效是检验治疗成败的标准。中医方药具有较低的“剂量阈”和较宽的“治疗窗”,这与临床病证的复杂性、患者的个体差异,以及患者对方药的反应性有密切关系。就药味及药量对防治脱发的临床疗效影响的内容概述如下:
药理学实验研究一。
1.材料与方法。
1.1实验药品。
药方组成及用量:一种治疗脱发的外用中药,按重量份数计,其组成及重量配比为:苦参10~20份、白鲜皮10~30份、地肤子10~20份、侧柏叶15~30份、桑叶15~30份、土茯苓15~20份、百部10~15份、半夏10~15份、石菖蒲15~20份、苍术10~30份、川芎10~25份、当归10~25份、鸡血藤10~25份、红花10~25份、牡丹皮10~20份、赤芍10~20份、紫草10~20份、防风10~20份、羌活10~30份、蔓荆子10~30份、白芷10~25份、车前草10~25份、泽泻10~30份、墨旱莲10~30份、何首乌10~30份、柴胡10~25份、桂枝10~20份、干姜10~25份、花椒5~15份、补骨脂10~30份、仙灵脾10~30份、甘草10~20份、薄荷10~25份。
根据药味及剂量划分为2组。
A组组方:苦参15g、白鲜皮15g、地肤子15g、侧柏叶20g、桑叶15g、土茯苓20g、百部15g、半夏15g、石菖蒲15g、苍术15g、川芎15g、当归15g、鸡血藤15g、红花10g、牡丹皮10g、赤芍15g、紫草10g、防风15g、羌活15g、蔓荆子15g、白芷15g、车前草15g、泽泻15g、墨旱莲15g、何首乌20g、柴胡15g、桂枝10g、干姜15g、花椒10g、补骨脂15g、仙灵脾15g、甘草15g、薄荷12g。
B组组方:苦参5g、白鲜皮5g、地肤子5g、侧柏叶10g、桑叶10g、土茯苓10g、百部5g、半夏5g、石菖蒲10g、苍术5g、川芎5g、当归5g、鸡血藤5g、红花10g、牡丹皮5g、赤芍5g、紫草10g、防风5g、羌活5g、蔓荆子5g、白芷5g、车前草5g、泽泻5g、墨旱莲5g、何首乌5g、柴胡5g、桂枝5g、干姜5g、花椒5g、补骨脂5g、仙灵脾5g、甘草5g、薄荷5g。
1.2动物分组。
健康雌雄各半小白鼠50只,22~30日龄,体重为22~28g,封闭群体系,由辽宁中医药大学动物实验中心提供。在实验条件下适应饲养1周,饲养环境温度保持在26℃,室内湿度控制在70%,保持室内自由通风。实验前每只小鼠选取背部1.5cm×2cm面积的皮毛,用3%苦味酸溶液染成黄色以确定脱毛区。除正常对照组外其余各组动物颈后皮下注射1mg/kg·d剂量的丙酸睾丸酮,每日1次,连续60d,造成脂脱模型。适应饲养结束后随机分为A组、B组,每组各25只。
1.3药物制取及用量。
将上述中药饮片以300ml75%的酒精泡制两周后,药渣丢弃,倒取上清药液,擦拭局部,2次/日即可。给药剂量参照《药典》内容:人(70kg)的临床用药量为0.035g/kg,通过人/小鼠体表面积比换算出小鼠的用药量。
1.4 观察指标。
每日观察小鼠背部皮肤变化及小鼠毛发的生长情况,用游标卡尺测定实验区小鼠毛长度。45d后从3cm2面积中连皮取下,取10根针毛制片,显微观察毛囊的变化。最后取实验区的皮肤组织,10%甲醛固定,沿毛囊纵向切面连续取3块组织,每块长1.5cm,进行常规组织脱水、石蜡包埋,HE染色,光镜镜检,观察小鼠皮肤组织。①真皮浅层血管管径(μm),随机测定5个横切毛细管管径,计算平均数;②真皮浅层血管数(个),以200倍视野大小计数,数5个视野,计算平均数;③真皮浅层新生毛囊数(个),以100倍视野大小计数,数5个视野,计算平均数。
1.5统计学处理。
本研究数据均采用SPSS22.0软件进行统计学分析。计量资料以(x±s)表示,采用t验;计数资料以n(%)表示,采用x2检验。P<0.05 为具有统计学差异。
2. 结果。
2.1 两组小鼠毛发生长情况。
由表可知,A组小鼠毛发生长长度显著优于同期B组小鼠,差异提示具有统计学意义(P<0.05)。
表1 两组小鼠毛发生长长度(mm)对比(n=25)。
注:*提示同期组间对比,P<0.05有统计学差异。
2.2两组小鼠背部皮肤组织学情况。
由表可知,A组在扩张小鼠真皮浅层毛细血管,增强局部血量,改善局部微循环,加强毛囊营养,促进毛发生长方面等背部皮肤组织学改变情况显著优于同期B组小鼠,差异具有统计学意义(P<0.05)。
表2 两组小鼠背部皮肤组织学情况对比(n=25)。
注:*提示同期组间对比,P<0.05有统计学差异。
由上述研究结果可知,临床上药味相同,剂量不同,疗效迥异的处方常用。关于中药药理学石试验和中医临床实践,发现量效关系具有重要作用,可概括为正确的药用剂量决定着疗效的成败,方剂中药物剂量比例对疗效直接影响,方剂中药物之间的剂量比例变化直接影响处方的治疗方向,药物生物活性的高低直接影响药物的剂量大小及中药的双向作用指导着药物剂量的大小五方面。故本次研究中针对明确的药味其剂量的把控严格遵守《中药药典》药量规定,同时也参照其中单味或复合药味药物防治脱发最佳药量的相关药理学试验结论,制定了本发明各药味的剂量,意在求其最佳疗效。如苦参5~20份降低ICAM-1和ELAM-1水平,抑制炎症细胞的迁移和趋化,减轻活化的促炎性白细胞攻击毛囊,抑制T淋巴细胞向毛囊浸润,减轻对毛囊细胞造成的炎症性和免疫性损伤,治疗脱发;当归10~25份改善毛囊局部微循环和营养代谢,减少退行期毛囊内细胞凋亡,抑制毛囊进入退行期,促进毛发生长。
实施例5。
药理学实验研究二。
1.材料与方法。
1.1实验药品。
药方组成及用量:一种治疗脱发的外用中药,按重量份数计,其组成及重量配比为:苦参10~20份、白鲜皮10~30份、地肤子10~20份、侧柏叶15~30份、桑叶15~30份、土茯苓15~20份、百部10~15份、半夏10~15份、石菖蒲15~20份、苍术10~30份、川芎10~25份、当归10~25份、鸡血藤10~25份、红花10~25份、牡丹皮10~20份、赤芍10~20份、紫草10~20份、防风10~20份、羌活10~30份、蔓荆子10~30份、白芷10~25份、车前草10~25份、泽泻10~30份、墨旱莲10~30份、何首乌10~30份、柴胡10~25份、桂枝10~20份、干姜10~25份、花椒5~15份、补骨脂10~30份、仙灵脾10~30份、甘草10~20份、薄荷10~25份。
根据药味及剂量划分为2组。
C组组方:苦参10g、白鲜皮10g、地肤子10g、侧柏叶15g、桑叶15g、土茯苓20g、百部15g、半夏15g、石菖蒲15g、苍术10g、川芎10g、当归10g、鸡血藤10g、红花10g、牡丹皮10g、赤芍10g、紫草10g、防风10g、羌活10g、蔓荆子10g、白芷10g、车前草10g、泽泻10g、墨旱莲10g、何首乌10g、柴胡10g、桂枝10g、干姜10g、花椒5g、补骨脂10g、仙灵脾10g、甘草10g、薄荷10g。
D组组方:地肤子10g、侧柏叶15g、桑叶15g、土茯苓20g、百部15g、半夏15g、石菖蒲15g、苍术10g、当归10g、鸡血藤10g、牡丹皮10g、赤芍10g、防风10g、羌活10g、白芷10g、泽泻10g、墨旱莲10g、何首乌10g、柴胡10g、桂枝10g、花椒5g、仙灵脾10g。
1.2动物分组。
健康雌雄各半小白鼠50只,23~30日龄,体重为21~28g,封闭群体系,由辽宁中医药大学动物实验中心提供。在实验条件下适应饲养1周,饲养环境温度保持在26℃,室内湿度控制在70%,保持室内自由通风。实验前每只小鼠选取背部1.5cm×2cm面积的皮毛,用3%苦味酸溶液染成黄色以确定脱毛区。除正常对照组外其余各组动物颈后皮下注射1mg/kg·d剂量的丙酸睾丸酮,每日1次,连续60d,造成脂脱模型。适应饲养结束后随机分为C组、D组,每组各25只。
1.3药物制取及用量。
将上述中药饮片以300ml75%的酒精泡制两周后,药渣丢弃,倒取上清药液,擦拭局部,2次/日即可。给药剂量参照《药典》内容:人(70kg)的临床用药量为0.035g/kg,通过人/小鼠体表面积比换算出小鼠的用药量。
1.4 观察指标。
每日观察小鼠背部皮肤变化及小鼠毛发的生长情况,用游标卡尺测定实验区小鼠毛长度。45d后从3cm2面积中连皮取下,取10根针毛制片,显微观察毛囊的变化。最后取实验区的皮肤组织,10%甲醛固定,沿毛囊纵向切面连续取3块组织,每块长1.5cm,进行常规组织脱水、石蜡包埋,HE染色,光镜镜检,观察小鼠皮肤组织。①真皮浅层血管管径(μm),随机测定5个横切毛细管管径,计算平均数;②真皮浅层血管数(个),以200倍视野大小计数,数5个视野,计算平均数;③真皮浅层新生毛囊数(个),以100倍视野大小计数,数5个视野,计算平均数。
1.5统计学处理。
本研究数据均采用SPSS22.0软件进行统计学分析。计量资料以(x±s)表示,采用t验;计数资料以n(%)表示,采用x2检验。P<0.05 为具有统计学差异。
3. 结果。
3.1 两组小鼠毛发生长情况。
由表可知,C组小鼠毛发生长长度显著优于同期D组小鼠,差异提示具有统计学意义(P<0.05)。
表3 两组小鼠毛发生长长度(mm)对比(n=25)
注:*提示同期组间对比,P<0.05有统计学差异。
2.2两组小鼠背部皮肤组织学情况
由表可知,C组在扩张小鼠真皮浅层毛细血管,增强局部血量,改善局部微循环,加强毛囊营养,促进毛发生长方面等背部皮肤组织学改变情况显著优于同期D组小鼠,差异具有统计学意义(P<0.05)。
表4 两组小鼠背部皮肤组织学情况对比(n=25)。
注:*提示同期组间对比,P<0.05有统计学差异。
由上述研究结果可知,药物的应用剂量相同,但药味的选择对于临床疗效的影响极其重要。肾之合骨也,其荣在发;肾藏精,生髓,髓充于骨而汇于脑,发为肾精之外候,精血充足则发浓密而光泽。通过挖掘数据研究指出,用药频次上,常用药物有当归、何首乌、熟地、川芎、侧柏叶、红花、当归、补骨脂;药物分类上,活血化瘀药占非补虚各类药物之首位;药味选择上,辛、甘、苦均占主位;在药性择类上,外用药物以偏温热的药物为主,其次是偏寒凉的药物,最后是平性药物;药物归经上,入五脏的归经占大部分,五脏中入肝经的最多,诸腑中以入胃经最多。故本次发明最终确定药味为苦参、白鲜皮、地肤子、侧柏叶、川芎、当归、鸡血藤、红花、防风、羌活、墨旱莲、何首乌、柴胡、补骨脂、仙灵脾等,全面覆盖脱发的发生、发展过程,契合病因、病机及病理衍变过程所出现的常规证候类型。
临床试验。
选取确诊为脱发患者60例,所有患者均符合《中国临床皮肤病学》中的诊断标准:发病突然,头部出现圆形或椭圆形斑状脱发,界限清晰:脱发区皮肤正常,无明显自觉症状,脱发区无明显萎缩及瘢痕,毛囊口清晰可见:局部可有轻度痒感,无全身症状。雄激素源性脱发,参考《中国临床皮肤病学》中的诊断标准:渐进性的脱发,从前额两侧开始,头发密度逐渐下降,头发纤细,稀疏并向头顶蔓延;脱发区可见纤细毳毛,皮肤光滑,头皮油脂多,或伴有瘙痒。中医诊断参照全国高等中医药院校教材《中医皮肤性病学》诊断标准:患者脱发成片,伴有头皮烘热、瘙痒,有虫蚁噬行感,烦躁不安,心烦易怒,苔薄或黄腻,舌质红,脉弦。并采用随机数字法抽取患者分为实验组与对照组,观察组男24例,女6例;年龄18~43(35±2.9)岁;病程2周~3年;斑秃15例,脂溢性脱发15例。对照组男25例,女5例;年龄18~45(37±3.4)岁;病程1个月~5年;斑秃16例,脂溢性脱发14例。两组患者性别、年龄、病程和脱发类型比较差异无统计学意义(P>0.05)。
观察组给予一种防脱发外用中药组合物擦拭头皮,待局部充分湿润后,嘱患者按摩头皮,增加头发对药物的吸收,2次/日。对照组采用2%米诺地尔酊(生产厂家:浙江万晟药业有限公司;生产批号国药准字H20010714)局部外用:每次1ml(米诺地尔50mg,约7喷),涂于头部患处,从患处的中心开始涂抹,并用手按摩3~5分钟,2次/日。两组均治疗6个月判定疗效。
(1)疗效标准参照《中药新药临床研究指导原则》内容,将疗效分为痊愈、显效、有效、无效4级。痊愈:毛发停止脱落脱发全部长出,其分布密度、粗细、色泽与健发区相同皮脂分泌恢复正常。显效:毛发停止脱落脱发再生达70%以上其密度、粗细及色泽均接近健发区皮脂分泌明显减少。有效:毛发停止脱落脱发再生达30%以上,包括毳毛及白发长出。无效:脱发再生不足30%或仍继续秃落。有效率=(治愈例数+显效例数+有效例数)/总例数×100%。(2)中医症状积标准参照《中药新药临床指导原则》内容,瘙痒程度、油腻程度、脱发情况、新生头发情况、鳞屑程度依照7分法原则计分,-3分(严重加重,加重程度≥70%)、-2分(中度加重,加重程度>30%~<70%)、-1分(轻度加重,加重程度≤30%)、0分(无变化)、1分(略改善,改善程度≤30%)、2分(中度改善,改善程度>30%~<70%)、3分(显著改善,改善程度≥70%)。(3)皮肤镜征象参考《临床皮肤病学》:以计数的形式记录两组患者治疗前后毛发直径差异大、毛周凹陷、头皮色素沉着及头皮炎症反应的变化。(4)安全性评价:;记录患者出现的不良反应,局部疼痛、红肿、瘙痒、头屑增多、头皮紧绷感、脱发增多等。
结果:(1)临床疗效:治疗组痊愈16例、显效7例、有效5例、无效2例,有效率为93.33%;对照组痊愈7例、显效9例、有效5例、无效9例,有效率为70.00%,说明采用一种防脱发外用中药组合物可有效改善临床症状,减缓疾病进程,提高生活质量。
(2)中医证候积分:治疗前,两组患者的瘙痒程度、油腻程度、脱发情况、新生头发情况、鳞屑程度积分均无显著性差异(P>0.05);治疗后,治疗组患者的瘙痒程度、油腻程度、脱发情况、新生头发情况、鳞屑程度积分均显著小于对照组(P<0.05)。(3)治疗前,两组患者皮肤镜征象(毛发直径差异大、毛周凹陷、头皮色素沉着、头皮炎症反应)无显著性差异(P>0.05);治疗后,治疗组患者的皮肤镜征象(毛发直径差异大、毛周凹陷、头皮色素沉着、头皮炎症反应)改善显著优于对照组(P<0.05)。(4)安全性评价:治疗组中有1例用药后出现局部刺激疼痛,1例微红肿;对照1组中有2例出现头皮局部灼热感,2例红肿,1例头皮瘙痒加重;两组的不良事件均比较轻微,通过停药或减量后都能缓解,差异无统计学意义(P>0.05)。
Claims (6)
1.一种预防脱发的外用中药组合物,其特征在于,按重量份数计,其组成及重量配比为:苦参10~20份、白鲜皮10~30份、地肤子10~20份、侧柏叶15~30份、桑叶15~30份、土茯苓15~20份、百部10~15份、半夏10~15份、石菖蒲15~20份、苍术10~30份、川芎10~25份、当归10~25份、鸡血藤10~25份、红花10~25份、牡丹皮10~20份、赤芍10~20份、紫草10~20份、防风10~20份、羌活10~30份、蔓荆子10~30份、白芷10~25份、车前草10~25份、泽泻10~30份、墨旱莲10~30份、何首乌10~30份、柴胡10~25份、桂枝10~20份、干姜10~25份、花椒5~15份、补骨脂10~30份、仙灵脾10~30份、甘草10~20份、薄荷10~25份。
2.一种预防脱发的外用中药组合物,其特征在于,按重量份数计,其组成及重量配比优选为:苦参15g、白鲜皮15g、地肤子15g、侧柏叶15g、桑叶15g、土茯苓20g、百部15g、半夏10g、石菖蒲15g、苍术15g、川芎15g、当归15g、鸡血藤15g、红花10g、牡丹皮15g、赤芍15g、紫草10g、防风15g、羌活15g、蔓荆子15g、白芷15g、车前草15g、泽泻15g、墨旱莲15g、何首乌15g、柴胡15g、桂枝10g、干姜15g、花椒10g、补骨脂15g、仙灵脾15g、甘草15g、薄荷12g。
3.一种预防脱发的外用中药组合物制备方法,将上述中药饮片以300ml 75%的酒精泡制两周后,药渣丢弃,倒取上清药液,制得。
4.根据权利要求1或权利要求2所述的中药组合物或者采用权利要求3所述的制备方法制备得到的中药组合物在制备治疗祛热燥湿、滋补肝肾、活血祛瘀和固发防脱的功效药物中的应用。
5.根据权利要4所述的应用,其特征在于,所述药物剂型为酊剂。
6.根据权利要4所述的应用,其特征在于,临床用药量为:0.035g所述药物对应于1千克人体体重,2次/日。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211045464.5A CN115120698B (zh) | 2022-08-30 | 2022-08-30 | 一种防脱发外用中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211045464.5A CN115120698B (zh) | 2022-08-30 | 2022-08-30 | 一种防脱发外用中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115120698A true CN115120698A (zh) | 2022-09-30 |
CN115120698B CN115120698B (zh) | 2023-07-25 |
Family
ID=83387175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211045464.5A Active CN115120698B (zh) | 2022-08-30 | 2022-08-30 | 一种防脱发外用中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115120698B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117398315A (zh) * | 2023-11-08 | 2024-01-16 | 珠海欧维斯科技有限公司 | 一种促进毛囊生发的组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107468968A (zh) * | 2017-08-28 | 2017-12-15 | 申宴鹏 | 白发转黑发、育发生发精华液及其制备方法 |
CN108186531A (zh) * | 2018-03-09 | 2018-06-22 | 广州市娇兰化妆品有限公司 | 一种生发育发精华液及制备方法与应用 |
CN113368212A (zh) * | 2021-07-27 | 2021-09-10 | 永宁县中医医院 | 治疗脱发的外用中药组和物及含该外用中药组合物的生发酊 |
-
2022
- 2022-08-30 CN CN202211045464.5A patent/CN115120698B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107468968A (zh) * | 2017-08-28 | 2017-12-15 | 申宴鹏 | 白发转黑发、育发生发精华液及其制备方法 |
CN108186531A (zh) * | 2018-03-09 | 2018-06-22 | 广州市娇兰化妆品有限公司 | 一种生发育发精华液及制备方法与应用 |
CN113368212A (zh) * | 2021-07-27 | 2021-09-10 | 永宁县中医医院 | 治疗脱发的外用中药组和物及含该外用中药组合物的生发酊 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117398315A (zh) * | 2023-11-08 | 2024-01-16 | 珠海欧维斯科技有限公司 | 一种促进毛囊生发的组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115120698B (zh) | 2023-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102049008B (zh) | 一种治疗黄褐斑的中药组合物及其制备方法 | |
CN101804185B (zh) | 美白祛斑中药复方提取物及其制备方法 | |
CN113368212A (zh) | 治疗脱发的外用中药组和物及含该外用中药组合物的生发酊 | |
CN115006336B (zh) | 一种防脱健发、去屑止痒植物洗发水及其制备方法 | |
CN1048156C (zh) | 参芪生发精 | |
CN103690854B (zh) | 一种具有生发防脱作用的外用中药组合物及其制备方法 | |
CN105616318A (zh) | 一种抗皱紧肤的积雪草中药面膜及其制备方法 | |
CN115120698B (zh) | 一种防脱发外用中药组合物及其制备方法 | |
CN112826900B (zh) | 一种治疗脂溢性脱发的中药组合物及其药物制剂 | |
CN117357624B (zh) | 一种育发防脱中药精油组合物及其制备方法和用途 | |
CN112656930A (zh) | 一种生发、乌发的中药洗发水及其制备方法 | |
CN105031032A (zh) | 一种用于治疗脱发的中药组合物、中药口服剂及其制备方法 | |
CN102416156B (zh) | 一种止脱生发的药物组合物的制备方法 | |
CN110269911A (zh) | 用于治疗脱发和白发转黑发的中药配方及其制备方法 | |
CN114533793A (zh) | 一种用于脂溢性脱发的中药组合物及其制备方法 | |
CN1250260C (zh) | 一种治疗鱼鳞病的药物 | |
CN105616984A (zh) | 一种益母草去皱美容膏及其制备方法 | |
CN114848558B (zh) | 一种防脱生发、白发转黑发的生发乌发液及其制备方法 | |
CN110755593A (zh) | 一种促进生发的中药组合物、制备方法及其使用方法 | |
CN113855747B (zh) | 治疗雄激素性脱发的中药组合物及其制备方法和应用 | |
CN118512517A (zh) | 一种治疗脂溢性脱发的中药组合物及中药洗剂及其制备方法 | |
CN117982611A (zh) | 一种生发护发中药组合物及其制备方法和应用 | |
CN105362478A (zh) | 一种治疗斑秃的中药 | |
CN104922642B (zh) | 用于治疗秃顶的外用中药组合物 | |
CN117860822A (zh) | 一种治疗脂溢性脱发的外用药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |